➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts

Last Updated: June 25, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for GSK1278863

Email this page to a colleague

« Back to Dashboard

What is the drug development status for GSK1278863?

GSK1278863 is an investigational drug.

There have been 25 clinical trials for GSK1278863. The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2016.

The most common disease conditions in clinical trials are Anemia, Renal Insufficiency, Chronic, and Kidney Diseases. The leading clinical trial sponsors are GlaxoSmithKline, PPD, and Octagon Research Solutions, Incoporated.

There are nine US patents protecting this investigational drug and ninety-eight international patents.

Recent Clinical Trials for GSK1278863
Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat in Non-Dialysis Subjects Evaluating Hemoglobin (Hgb) and Quality of Life (ASCEND-NHQ)GlaxoSmithKlinePhase 3
Absorption and Elimination of Radiolabeled DaprodustatGlaxoSmithKlinePhase 1
Daprodustat Hepatic Impairment StudyGlaxoSmithKlinePhase 1

See all GSK1278863 clinical trials

Clinical Trial Summary for GSK1278863

Top disease conditions for GSK1278863
Top clinical trial sponsors for GSK1278863

See all GSK1278863 clinical trials

US Patents for GSK1278863

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
GSK1278863   Get Started Free Controlled release dosage form TRIASTEK, INC. (Nanjing, CN)   Get Started Free
GSK1278863   Get Started Free Bicyclic-fused heteroaryl or aryl compounds as IRAK4 modulators Pfizer Inc. (New York, NY)   Get Started Free
GSK1278863   Get Started Free Oral drug dosage forms having desired drug release profiles and uses thereof Triastek, Inc. (Nanjing, CN)   Get Started Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.